
1. int j parasitol drugs drug resist. 2016 dec;6(3):179-183. doi:
10.1016/j.ijpddr.2016.09.003. epub 2016 sep 22.

human dihydrofolate reductase influences sensitivity malaria parasite 
plasmodium falciparum ketotifen - cautionary tale screening transgenic
parasites.

tran pn(1), tate cj(1), ridgway mc(1), saliba kj(2), kirk k(1), maier ag(3).

author information: 
(1)research school biology, australian national university, canberra, act,
2601, australia.
(2)research school biology, australian national university, canberra, act,
2601, australia; medical school, australian national university, canberra,
act, 2601, australia.
(3)research school biology, australian national university, canberra, act,
2601, australia. electronic address: alex.maier@anu.edu.au.

ketotifen recently reported inhibit growth asexual and
sexual malaria parasites. parasite transporter, pfgabcg2, implicated
in mechanism action. human dihydrofolate reductase (hdhfr) most
commonly used selectable marker create transgenic plasmodium falciparum cell
lines. growth assays using transgenic p. falciparum parasites different
selectable markers revealed presence hdhfr rather absence of
pfgabcg2 responsible shift parasite's sensitivity ketotifen.
employing range in vitro assays liquid chromatography-mass spectrometry 
we show ketotifen influences hdhfr activity, metabolised by
the enzyme. data also highlights potential pitfalls functionally
characterising transgenic parasites.

copyright © 2016 authors. published elsevier ltd.. rights reserved.

doi: 10.1016/j.ijpddr.2016.09.003 
pmcid: pmc5050295
pmid: 27705841  [indexed medline]

